RAMM Pharma (XCNQ:RAMM) Interest Income : C$0.00 Mil (TTM As of Jan. 2025)

View and export this data going back to 2019. Start your Free Trial

What is RAMM Pharma Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. RAMM Pharma's interest income for the three months ended in Jan. 2025 was C$0.00 Mil. Its interest income for the trailing twelve months (TTM) ended in Jan. 2025 was C$0.00 Mil.

RAMM Pharma Interest Income Historical Data

The historical data trend for RAMM Pharma's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RAMM Pharma Interest Income Chart

RAMM Pharma Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Interest Income

Get a 7-Day Free Trial

0.33

0.37

0.16

0.20

0.03

RAMM Pharma Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Interest Income	Get a 7-Day Free Trial															0.03	0.02	0.02	-0.05	-

RAMM Pharma Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

RAMM Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RAMM Pharma Corp (XCNQ:RAMM) » Definitions » Interest Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street E, Toronto, ON, CAN, M5C 1P1

Website

https://www.rammpharma.com

RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.

Executives

Jackie Peter Burnett	10% Security Holder, Director, Senior Officer
Armando Gabriel Blankleider	Director

RAMM Pharma Headlines

No Headlines